UnitedHealth Group has been a reliable megacap for years. Its sudden decline in recent months is raising questions about the future fate of its stock.

Experts say it’s no surprise that UnitedHealthcare often ends up in the crosshairs of public and political scrutiny, as it’s the nation’s largest insurer.

UnitedHealth Group has been hit by multiple negative developments over the last week. Few stocks have been as resilient as ...

Investing.com - UnitedHealth Group (NYSE:UNH) faces risks to earnings growth despite a recent leadership shake-up, analysts at HSBC said in a note to clients downgrading their rating of the healthcare ...

Novo Nordisk, maker of weight loss drug Wegovy, says CEO Lars Fruergaard Jorgensen is leaving the company by "mutual ...

Novo Nordisk’s new top executive will need to help the company close the gap with Eli Lilly, fend off emerging rivals and ...

Wolfe Research lowered the price target on UnitedHealth Group Incorporated (NYSE:UNH) from $501 to $390, keeping an ...

CEO Andrew Witty this week has sent shockwaves through an already tumultuous healthcare sector. Investors in UNH stock have ...

Lars Fruergaard Jørgensen is stepping down as Novo Nordisk CEO, with the company citing its stock's recent struggles.

Novo’s shares have plunged since hitting a record-high in June last year as competition, particularly from Eli Lilly, makes inroads into its market share and as its pipeline of new drugs has ...

Meanwhile, in our recent survey of over 3,000 executives on LinkedIn at the vice president level or higher, 63 percent agreed that A.I. will eventually take on some of the mundane tasks currently ...